House committee uncovers how Humira’s price spiked by 470% as AbbVie execs cashed bonuses tied to the hikes

Prior to the House Committee on Oversight’s grilling of AbbVie CEO Richard Gonzalez on Tuesday, the committee staff released a 57-page report following a two year investigation into how and why the company spiked the price of Humira (adalimumab) and made it the highest-grossing drug of all time.

While the...

Click to view original post